NCT00700102 · OUTCOME
Participants With Progression Free Survival Event
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- participants
- Interval / dispersion
- Not reported
- Time frame
- within 6.5 years
Analysis population: Unstratified intention to treat population
Groups in this outcome
Chemotherapy
Chemotherapy alone until disease progression, unacceptable toxicity, or patient refusal
Chemotherapy + Bevacizumab
Chemotherapy and Bevacizumab until disease progression, unacceptable toxicity, or patient refusal
| Group | Source count |
|---|---|
| Chemotherapy | 410 |
| Chemotherapy + Bevacizumab | 409 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Chemotherapy | 394 | Not reported | Not reported | Not reported | Not reported |
| Chemotherapy + Bevacizumab | 386 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 394
- group Id
- OG001
- value
- 386
- denoms
- counts
- group Id
- OG000
- value
- 410
- group Id
- OG001
- value
- 409
- units
- Participants
- groups
- description
- Chemotherapy alone until disease progression, unacceptable toxicity, or patient refusal
- id
- OG000
- title
- Chemotherapy
- description
- Chemotherapy and Bevacizumab until disease progression, unacceptable toxicity, or patient refusal
- id
- OG001
- title
- Chemotherapy + Bevacizumab
- param Type
- NUMBER
- population Description
- Unstratified intention to treat population
- reporting Status
- POSTED
- time Frame
- within 6.5 years
- title
- Participants With Progression Free Survival Event
- type
- SECONDARY
- unit Of Measure
- participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle